Penumbra
PEN
NZ$412.74
Share price
-1.07%
Change (1 day)
41.16%
Change (1 year)
Categories
Penumbra, Inc., is an American company that develops, manufactures and sells medical devices for neurovascular and vascular medicine applications.
Penumbra (PEN) - Total debt
Total debt on the balance sheet as of March 2025 : NZ$0.36 Billion
According to Penumbra's latest financial reports the company's total debt is NZ$0.36 Billion. A company’s total debt is the sum of all current and non-current debts.
Penumbra - Total debt on balance sheet (from 2018 to 2025)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | NZ$0.39 B | 6.89% |
| 2023-12-31 | NZ$0.37 B | -0.21% |
| 2022-12-31 | NZ$0.37 B | 46.16% |
| 2021-12-31 | NZ$0.25 B | 137.24% |
| 2020-12-31 | NZ$0.10 B | -12.35% |
| 2019-12-31 | NZ$0.12 B | |
| 2018-12-31 | N/A | |
| 2013-12-31 | NZ$7.3 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 Inari Medical
NARI | NZ$54.38 M | -85.17% | 🇺🇸 USA |
 Merit Medical MMSI | NZ$1.35 B | 270.56% | 🇺🇸 USA |